Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-26-126833·ARK Investment Management LLC
Schedule 13G ownership disclosure
RECURSION PHARMACEUTICALS INC CL A
Class A Common Stock · CUSIP: 75629V104
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ARK Investment Management LLC
Shares: 44,745,024.00 · Class: 8.36%
- Catherine D. Wood
Shares: 44,745,024.00 · Class: 8.36%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-126833
- Form type
- SCHEDULE 13G/A
- Filer
- ARK Investment Management LLC
- CIK
- CIK 1697748
- Filed
- Nov 13, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership